PubMed

Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine.

Dimopoulos MA, Kantarjian H, Estey E, O'Brien S, Delasalle K, Keating MJ, Freireich EJ, Alexanian R.

Ann Intern Med. 1993 Feb 1;118(3):195-8.PMID: 8093333 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.

Dimopoulos MA, Kantarjian H, Weber D, O'Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R.

J Clin Oncol. 1994 Dec;12(12):2694-8.PMID: 7989946 [PubMed - indexed for MEDLINE]Related articles

Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors.

Dimopoulos MA, Weber D, Delasalle KB, Keating M, Alexanian R.

Ann Oncol. 1995 Jan;6(1):49-52.PMID: 7710983 [PubMed - indexed for MEDLINE]Related articles

Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.

Dimopoulos MA, O'Brien S, Kantarjian H, Estey EE, Keating MJ, Alexanian R.

Leuk Lymphoma. 1993;11 Suppl 2:105-8.PMID: 7907250 [PubMed - indexed for MEDLINE]Related articles

Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia.

Hellmann A, Lewandowski K, Zaucha JM, Bieniaszewska M, Hałaburda K, Robak T.

Eur J Haematol. 1999 Jul;63(1):35-41.PMID: 10414453 [PubMed - indexed for MEDLINE]Related articles

2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.

Weber DM, Dimopoulos MA, Delasalle K, Rankin K, Gavino M, Alexanian R.

Semin Oncol. 2003 Apr;30(2):243-7.PMID: 12720145 [PubMed - indexed for MEDLINE]Related articles

2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.

Delannoy A, Ferrant A, Martiat P, Bosly A, Zenebergh A, Michaux JL.

Nouv Rev Fr Hematol. 1994 Aug;36(4):317-20.PMID: 7971252 [PubMed - indexed for MEDLINE]Related articles

Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia.

Liu ES, Burian C, Miller WE, Saven A.

Br J Haematol. 1998 Dec;103(3):690-5.PMID: 9858218 [PubMed - indexed for MEDLINE]Related articles

Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.

Tetreault SA, Saven A.

Leuk Lymphoma. 2000 Mar;37(1-2):125-30.PMID: 10721776 [PubMed - indexed for MEDLINE]Related articles

First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie.

Fridrik MA, Jäger G, Baldinger C, Krieger O, Chott A, Bettelheim P.

Ann Hematol. 1997 Jan;74(1):7-10.PMID: 9031608 [PubMed - indexed for MEDLINE]Related articles

2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature.

Lewandowski K, Zaucha JM, Bieniaszewska M, Hałaburda K, Hellmann A.

Med Sci Monit. 2000 Jul-Aug;6(4):740-5. Review.PMID: 11208402 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.

Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Höfler G, Linkesch W, Raderer M.

J Clin Oncol. 2002 Sep 15;20(18):3872-7.PMID: 12228207 [PubMed - indexed for MEDLINE]Related articles

2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.

Dimopoulos MA, Weber DM, Kantarjian H, Keating M, Alexanian R.

Ann Oncol. 1994 Mar;5(3):288-9.PMID: 7514439 [PubMed - indexed for MEDLINE]Related articles

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK).

Betticher DC, Hsu Schmitz SF, Ratschiller D, von Rohr A, Egger T, Pugin P, Stalder M, Hess U, Fey MF, Cerny T.

Br J Haematol. 1997 Nov;99(2):358-63.PMID: 9375754 [PubMed - indexed for MEDLINE]Related articles

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.

Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D.

Haematologica. 1999 Jan;84(1):22-5.PMID: 10091389 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.

Kornblau SM, Gandhi V, Andreeff HM, Beran M, Kantarjian HM, Koller CA, O'Brien S, Plunkett W, Estey E.

Leukemia. 1996 Oct;10(10):1563-9.PMID: 8847890 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.

Saven A, Burian C, Koziol JA, Piro LD.

Blood. 1998 Sep 15;92(6):1918-26.PMID: 9731048 [PubMed - indexed for MEDLINE]Related articlesFree article

Fludarabine therapy in Waldenström's macroglobulinemia.

Dimopoulos MA, O'Brien S, Kantarjian H, Pierce S, Delasalle K, Barlogie B, Alexanian R, Keating MJ.

Am J Med. 1993 Jul;95(1):49-52.PMID: 8328496 [PubMed - indexed for MEDLINE]Related articles

Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.

Lewandowski K, Halaburda K, Hellmann A.

Leuk Lymphoma. 2002 Feb;43(2):361-3.PMID: 11999570 [PubMed - indexed for MEDLINE]Related articles

2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis.

Zaucha JM, Hałaburda K, Ciepłuch H, Hellmann A.

Acta Haematol Pol. 1994;25(2):119-27.PMID: 7915075 [PubMed - indexed for MEDLINE]Related articles